“The future of cannabinoids is here,” said Justin Hamilton, CEO of Hempleton Investment Group, which co-developed the products with Volunteer Botanicals. “Prolifera hemp-derived cannabinoid tablets are engineered with pharmaceutical technology that produces a consistent, instant-release dose of CBD and a boosted dose of minor cannabinoids to help amplify CBD benefits. When we discovered how Volunteer Botanicals’ technology could compound cannabinoids into easy-to-ingest, familiar form factors, we knew we had to work together. This is how we integrate CBD and minor cannabinoids into people’s everyday regimens.”